We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Molecular Biomarkers for the Early Detection of Ovarian Cancer.
- Authors
Zhang, Ruiqian; Siu, Michelle K. Y.; Ngan, Hextan Y. S.; Chan, Karen K. L.
- Abstract
Ovarian cancer is the deadliest gynecological cancer, leading to over 152,000 deaths each year. A late diagnosis is the primary factor causing a poor prognosis of ovarian cancer and often occurs due to a lack of specific symptoms and effective biomarkers for an early detection. Currently, cancer antigen 125 (CA125) is the most widely used biomarker for ovarian cancer detection, but this approach is limited by a low specificity. In recent years, multimarker panels have been developed by combining molecular biomarkers such as human epididymis secretory protein 4 (HE4), ultrasound results, or menopausal status to improve the diagnostic efficacy. The risk of ovarian malignancy algorithm (ROMA), the risk of malignancy index (RMI), and OVA1 assays have also been clinically used with improved sensitivity and specificity. Ongoing investigations into novel biomarkers such as autoantibodies, ctDNAs, miRNAs, and DNA methylation signatures continue to aim to provide earlier detection methods for ovarian cancer. This paper reviews recent advancements in molecular biomarkers for the early detection of ovarian cancer.
- Subjects
EARLY detection of cancer; AUTOANTIBODIES; OVARIAN cancer; BIOMARKERS; DNA methylation; DELAYED diagnosis
- Publication
International Journal of Molecular Sciences, 2022, Vol 23, Issue 19, p12041
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms231912041